Canadian Association of Emergency Physicians   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Ottawa Canada (1999)

Organization Overview

First Clinical Trial
2005
NCT00124787
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Canadian Association of Emergency Physicians

Active Ingredients

Drugs in Phase 4 Trials (2)

dimenhydrinate (1 trial)

sucrose (1 trial)

Drugs in Phase 2 Trials (1)

valaciclovir (Valtrex) (1 trial)

Drugs in Phase 1 Trials (1)

cephalexin (keflex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cellulitis (Phase 1)

Gastroenteritis (Phase 4)

Stomatitis (Phase 2)

Stomatitis, Herpetic (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4